Development and Technical Validation of a Smartphone-Based Cry Detection Algorithm

by Ahnjili ZhuParris, Matthijs D. Kruizinga, Matthijs D. Kruizinga, Matthijs D. Kruizinga, Max van Gent, Max van Gent, Eva Dessing, Eva Dessing, Vasileios Exadaktylos, Robert Jan Doll, Frederik E. Stuurman, Frederik E. Stuurman, Gertjan A. Driessen, Gertjan A. Driessen, Adam F. Cohen, Adam F. Cohen
Published 2021-04-01

Repeatability and predictive value of lactate threshold concepts in endurance sports.

by Jules A A C Heuberger, Pim Gal, Frederik E Stuurman, Wouter A S de Muinck Keizer, Yuri Mejia Miranda, Adam F Cohen
Published 2018-01-01

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resis...

by Josephina P. M. Vrouwe, Ingrid M. C. Kamerling, Michiel J. vanEsdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van derPluijm, Jacobus Burggraaf, Susanne Osanto
Published 2021-10-01

No relation between docetaxel administration route and high‐grade diarrhea incidence

by Jeroen J. M. A. Hendrikx, Frederik E. Stuurman, Ji‐Ying Song, Vincent A. deWeger, Jurjen S. Lagas, Hilde Rosing, Jos H. Beijnen, Alfred H. Schinkel, Jan H. M. Schellens, Serena Marchetti
Published 2020-08-01

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?

by Aliede E. in ‘t Veld, Hendrika W. Grievink, Mahdi Saghari, Frederik E. Stuurman, Marieke L. de Kam, Aiko P. J. de Vries, Brenda C. M. de Winter, Jacobus Burggraaf, Adam F. Cohen, Matthijs Moerland
Published 2019-09-01

Objective Home-Monitoring of Physical Activity, Cardiovascular Parameters, and Sleep in Pediatric Obesity

by Janine M. Knijff, Euphemia C.A.M. Houdijk, Daniëlle C.M. van der Kaay, Youri van Berkel, Luc Filippini, Frederik E. Stuurman, Adam F. Cohen, Gertjan J.A. Driessen, Matthijs D. Kruizinga
Published 2022-03-01

Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs

by Guilherme S. Ferreira, Francis M. Dijkstra, Désirée H. Veening-Griffioen, Wouter P. C. Boon, Huub Schellekens, Ellen H. M. Moors, Peter J. K. van Meer, Frederik E. Stuurman, Joop M. A. van Gerven
Published 2023-03-01

Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis

by Amee Sonigra, Hendrik J. Nel, Pascale Wehr, Nishta Ramnoruth, Swati Patel, Karin A. van Schie, Maxwell W. Bladen, Ahmed M. Mehdi, Joanne Tesiram, Meghna Talekar, Jamie Rossjohn, Hugh H. Reid, Frederik E. Stuurman, Helen Roberts, Phillip Vecchio, Ian Gourley, Mark Rigby, Stephane Becart, Rene E.M. Toes, Hans Ulrich Scherer, Kim-Anh Lê Cao, Kim Campbell, Ranjeny Thomas
Published 2022-10-01